Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 5
1951 2
1952 2
1953 12
1954 5
1955 8
1956 19
1957 7
1958 11
1959 4
1960 4
1961 8
1962 14
1963 5
1964 4
1965 1
1966 3
1967 3
1968 3
1969 8
1970 3
1971 3
1972 2
1973 5
1974 4
1975 3
1976 4
1977 11
1978 4
1979 2
1980 8
1981 8
1982 3
1983 1
1984 5
1985 5
1986 4
1987 3
1988 8
1989 8
1990 1
1991 10
1992 15
1993 18
1994 7
1995 11
1996 24
1997 11
1998 8
1999 10
2000 11
2001 11
2002 12
2003 20
2004 20
2005 22
2006 29
2007 19
2008 21
2009 26
2010 29
2011 19
2012 18
2013 15
2014 22
2015 22
2016 22
2017 24
2018 16
2019 18
2020 14
2021 17
2022 12
Text availability
Article attribute
Article type
Publication date

Search Results

735 results
Results by year
Filters applied: . Clear all
Page 1
Future treatments for hereditary hemorrhagic telangiectasia.
Robert F, Desroches-Castan A, Bailly S, Dupuis-Girod S, Feige JJ. Robert F, et al. Orphanet J Rare Dis. 2020 Jan 7;15(1):4. doi: 10.1186/s13023-019-1281-4. Orphanet J Rare Dis. 2020. PMID: 31910860 Free PMC article. Review.
Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension.
Tu L, Desroches-Castan A, Mallet C, Guyon L, Cumont A, Phan C, Robert F, Thuillet R, Bordenave J, Sekine A, Huertas A, Ritvos O, Savale L, Feige JJ, Humbert M, Bailly S, Guignabert C. Tu L, et al. Among authors: robert f. Circ Res. 2019 Mar 15;124(6):846-855. doi: 10.1161/CIRCRESAHA.118.313356. Circ Res. 2019. PMID: 30636542 Free article.
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study.
Rudin CM, Pietanza MC, Bauer TM, Ready N, Morgensztern D, Glisson BS, Byers LA, Johnson ML, Burris HA 3rd, Robert F, Han TH, Bheddah S, Theiss N, Watson S, Mathur D, Vennapusa B, Zayed H, Lally S, Strickland DK, Govindan R, Dylla SJ, Peng SL, Spigel DR; SCRX16-001 investigators. Rudin CM, et al. Among authors: robert f. Lancet Oncol. 2017 Jan;18(1):42-51. doi: 10.1016/S1470-2045(16)30565-4. Epub 2016 Dec 5. Lancet Oncol. 2017. PMID: 27932068 Free PMC article. Clinical Trial.
Leukaemia cutis.
Kumar N, Yadav S, Reddy V, Robert F. Kumar N, et al. Among authors: robert f. Lancet. 2012 Sep 29;380(9848):1179. doi: 10.1016/S0140-6736(12)60352-3. Epub 2012 Jun 15. Lancet. 2012. PMID: 22704804 No abstract available.
Exploiting cyanobacterial P450 pathways.
Robert FO, Pandhal J, Wright PC. Robert FO, et al. Curr Opin Microbiol. 2010 Jun;13(3):301-6. doi: 10.1016/j.mib.2010.02.007. Epub 2010 Mar 17. Curr Opin Microbiol. 2010. PMID: 20299274 Review.
On the Origin of the Non-Planarity in Biarylsilyloxonium Ions.
Fernandes AJ, Robert F, Landais Y, Künzler S, Müller T. Fernandes AJ, et al. Among authors: robert f. Chemistry. 2021 Nov 5;27(62):15496-15500. doi: 10.1002/chem.202102614. Epub 2021 Oct 5. Chemistry. 2021. PMID: 34472137
735 results